ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.

Athanassios Argiris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.